Integer Holdings saw a positive market reaction to its fourth quarter results, as revenue and non-GAAP earnings per share both exceeded Wall Street expectations. Management cited strong performance in the Cardio & Vascular segment, particularly from acquisitions and demand in neurovascular, as a primary driver. CEO Peyman Khales emphasized the role of operational improvements and disciplined expense management, noting, "Operational improvements accounted for $30 million, or $0.86 per share, and reflected the benefits of higher sales volume, manufacturing efficiencies, operating expense management, and acquisition performance." The company’s product development pipeline and recent investments in manufacturing were also highlighted as contributors to the quarter's results.
Is now the time to buy ITGR? Find out in our full research report (it’s free for active Edge members).
Integer Holdings (ITGR) Q4 CY2025 Highlights:
- Revenue: $472.1 million vs analyst estimates of $462.7 million (5% year-on-year growth, 2% beat)
- Adjusted EPS: $1.76 vs analyst estimates of $1.70 (3.6% beat)
- Adjusted EBITDA: $106 million vs analyst estimates of $104.2 million (22.5% margin, 1.7% beat)
- Adjusted EPS guidance for the upcoming financial year 2026 is $6.54 at the midpoint, beating analyst estimates by 3.8%
- EBITDA guidance for the upcoming financial year 2026 is $402.5 million at the midpoint, in line with analyst expectations
- Operating Margin: 11.8%, in line with the same quarter last year
- Organic Revenue rose 2% year on year (beat)
- Market Capitalization: $2.98 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Integer Holdings’s Q4 Earnings Call
- Brett Adam Fishbin (KeyBanc Capital Markets) questioned the reason behind narrowing the top end of organic sales guidance. CEO Peyman Khales clarified there were no significant customer forecast changes, and the adjustment was due to rounding rather than a change in demand outlook.
- Richard Samuel Newitter (Truist Securities) asked about the steep first quarter margin decline and absorption of fixed costs. CFO Diron Smith explained that lower sales volumes early in the year make it harder to absorb fixed costs, but margins should improve as sales ramp up.
- Andrew Harris Cooper (Raymond James) inquired about the path back to outperforming market growth in 2027. CEO Peyman Khales pointed to a strong core business, new product launches, and the absence of current headwinds as the main drivers for returning to above-market growth.
- Joanne Karen Wuensch (Citigroup) asked if recent internal or external factors, such as activist involvement, led to changes in strategy. Khales said there have been no changes, reaffirming belief in the current strategy and approach to shareholder value creation.
- Suraj Kalia (Oppenheimer) sought clarity on fixed cost absorption and production flexibility when customer demand shifts. Khales described collaborative planning processes with customers and the use of long-term contracts, while Smith explained that manufacturing fixed costs are managed on a rolling basis to address quarter-to-quarter variability.
Catalysts in Upcoming Quarters
The StockStory team will be watching (1) the pace at which new product adoption recovers after recent headwinds, (2) the impact of pipeline launches in high-growth markets like electrophysiology and neuromodulation, and (3) the company’s ability to expand margins as sales stabilize and operational improvements take hold. Execution on the accelerated ERP modernization and facility expansions will also be key signposts for long-term scalability.
Integer Holdings currently trades at $84.15, down from $86.48 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
